ibet

EN
ibet¡¤(¼¯ÍÅ)ÓÐÏÞ¹«Ë¾¹ÙÍø
Chronic Disease Medication Innovation Platform

Âý²¡Ò©´´ÐÂÆ½Ì¨

¾ß±¸ÁË´´ÐÂÒ©´ÓÍ·Ñз¢£¬£¬ £¬ £¬£¬ £¬£¬£¬ÒÔ¼°¸ß¶Ë¿Ú·þ»º¿ØÊÍÖÆ¼ÁµÄÑз¢Éú²úÄÜÁ¦

¶à¸ö´´ÐÂÒ©Î↑չȫÇòÁÙ´²ÊÔÑé

 


· ½¨ÓÐÂý²¡´´ÐÂÒ©¼¼ÊõÖÐÐÄ¡¢¿Ú·þ»º¿ØÊÍÖÆ¼ÁÑо¿ÊµÑéÊÒºÍÉú²ú¼¼Êõת»¯ÖÐÐÄ£¬£¬ £¬ £¬£¬ £¬£¬£¬¾ß±¸´´ÐÂÒ©È«Á÷³Ì¼°¶àÖÖ¼¼ÊõÀàÐ͸߶˿ڷþ»º¿ØÊÍÖÆ¼ÁµÄ×ÔÖ÷Ñз¢¼°Éú²úÄÜÁ¦¡£¡£¡£ ¡£ ¡£¡£¡£¡£

 

· Óë¹ãÖÝʵÑéÊÒ¹²½¨´´ÐÂÒ©¼¼Êõ²úҵת»¯ÖÐÐÄ£¬£¬ £¬ £¬£¬ £¬£¬£¬¼Ó¿ì´´ÐÂÒ©Ñз¢Éú²ú£¬£¬ £¬ £¬£¬ £¬£¬£¬´Ù½ø´´ÐÂÒ©²úÒµµÄ·¢Õ¹£¬£¬ £¬ £¬£¬ £¬£¬£¬ÊµÏÖ¿ÆÑÐÏîÄ¿³É¹ûת»¯¡£¡£¡£ ¡£ ¡£¡£¡£¡£

 

  • ibet¡¤(¼¯ÍÅ)ÓÐÏÞ¹«Ë¾¹ÙÍø
    ºËÐÄÓÅÊÆ
      • Òѽ¨Á¢Âý²¡´´ÐÂÒ©¼¼ÊõÖÐÐÄ¡¢¿Ú·þ»º¿ØÊÍÖÆ¼ÁÑо¿ÊµÑéÊÒºÍÉú²ú¼¼Êõת»¯ÖÐÐÄ

      • ¾ß±¸´´ÐÂÒ©È«Á÷³Ì¼°¶àÖÖ¼¼ÊõÀàÐ͸߶˿ڷþ»º¿ØÊÍÖÆ¼ÁµÄ×ÔÖ÷Ñз¢¼°Éú²úÄÜÁ¦

      • Óë¹ãÖÝʵÑéÊÒ¹²½¨´´ÐÂÒ©¼¼Êõ²úҵת»¯ÖÐÐÄ£¬£¬ £¬ £¬£¬ £¬£¬£¬¼Ó¿ì´´ÐÂÒ©Ñз¢Éú²ú£¬£¬ £¬ £¬£¬ £¬£¬£¬´Ù½ø´´ÐÂÒ©²úÒµµÄ·¢Õ¹£¬£¬ £¬ £¬£¬ £¬£¬£¬ÊµÏÖ¿ÆÑÐÏîÄ¿³É¹ûת»¯

  • ibet¡¤(¼¯ÍÅ)ÓÐÏÞ¹«Ë¾¹ÙÍø
    ²úÆ·¹ÜÏß
      • ÒÑÓÐ66¸öÂý²¡Ò©×¢²áÅú¼þ

      • º­¸ÇÐÄÄÔѪ¹Ü¼²²¡¡¢ÉöÔ༲²¡¡¢Ïû»¯ÏµÍ³¼²²¡¡¢¸Î²¡µÈ¼²²¡ÖÎÁÆÁìÓò

  • ibet¡¤(¼¯ÍÅ)ÓÐÏÞ¹«Ë¾¹ÙÍø
    ÔÚÑйÜÏß
      • ÔÚÑÐÂý²¡Ò©°üÀ¨È«Çò´´ÐÂÒ©AR882µÈÏîÄ¿13¸ö

      • ¾ù¾ßÓжÀ¼ÒרÀûºÍ¶ÀÌØÖÎÁÆÓÅÊÆ

      • ÔÚÑÐÍ´·ç´´ÐÂÎïAR882Ч¹ûÓÅÓÚÁÙ´²Ò»ÏßÒ©Î£¬ £¬ £¬£¬ £¬£¬£¬¾ßÓÐÈ«Çò¾ºÕùÓÅÊÆ

  • ibet¡¤(¼¯ÍÅ)ÓÐÏÞ¹«Ë¾¹ÙÍø
    ÓÅÐã³É¹û
      • AR882ÒÑÍê³ÉµÄÈ«Çò¶àÖÐÐÄ¢òBÆÚÁÙ´²ÊÔÑéÊý¾ÝÏÔʾ£ºAR882ÁÆÐ§¸üÏÔÖø£¬£¬ £¬ £¬£¬ £¬£¬£¬°²È«ÐÔ¸ü¸ß£¬£¬ £¬ £¬£¬ £¬£¬£¬¾ßÓгÉΪFirst-in-class ¼° Best-in-classÓÅÊÆ²úƷDZÁ¦£¬£¬ £¬ £¬£¬ £¬£¬£¬ÒÑ»ñµÃÃÀ¹úFDAÊÚÓèµÄ¿ìËÙͨµÀ×ʸñ£¨FTD£©

      • ¶à¸ö²úÆ·ÈëÑ¡¡¶¹ú¼Ò»ù±¾Ò©ÎïĿ¼¡·ºÍ¡¶¹ú¼ÒÒ½±£Ä¿Â¼¡·

È«Çò´´ÐÂÒ©AR882Ñз¢½ø¶È

ibet¡¤(¼¯ÍÅ)ÓÐÏÞ¹«Ë¾¹ÙÍø

Âý²¡Ò©Ñз¢¹ÜÏß

ibet¡¤(¼¯ÍÅ)ÓÐÏÞ¹«Ë¾¹ÙÍø

ibet¡¤(¼¯ÍÅ)ÓÐÏÞ¹«Ë¾¹ÙÍø

 

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿